Differences among young adults, adults and elderly chronic myeloid leukemia patientsFabio Castagnetti, Mariella Girasoli, Gabriele Gugliotta et al.|Annals of Oncology|2014Cited by 99
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter seriesAlessandra Iurlo, Michele Baccarani, Sara Galimberti et al.|Annals of Hematology|2017Cited by 38
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcomeAlessandra Iurlo, Pier Mannuccio Mannucci, Alessandro Nobili et al.|Oncotarget|2016Cited by 35
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasmsLuigi Gugliotta, Alessandro M. Vannucchi, Alessandra Iurlo et al.|Leukemia Research|2016Cited by 15
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone LymphomaCamilla Mazzoni, Pier Luigi Zinzani, Lisa Argnani et al.|European Journal Of Haematology|2024Cited by 3